Zobrazeno 1 - 10
of 238
pro vyhledávání: '"Giorgio La Nasa"'
Autor:
Alessandro Costa, Raimondo Pittorru, Giovanni Caocci, Federico Migliore, Francesco Tona, Olga Mulas, Giorgio La Nasa
Publikováno v:
Hemato, Vol 4, Iss 3, Pp 207-226 (2023)
Since their introduction, tyrosine kinase inhibitors (TKIs) have radically changed the treatment paradigm of Chronic Myeloid Leukemia (CML), leading to deep and lasting molecular responses and profoundly influencing survival. However, cancer-therapy-
Externí odkaz:
https://doaj.org/article/45149ed28cbb417883ff0bd9e6cfab92
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
Extracellular vesicles (EVs) are various sets of cell-derived membranous structures containing lipids, nucleic acids, and proteins secreted by both eukaryotic and prokaryotic cells. It is now well recognized that EVs are key intercellular communicati
Externí odkaz:
https://doaj.org/article/0b4fe55c5bc34936a03e5074150f2120
Autor:
Francesco Saraceni, Myriam Labopin, Anna M. Raiola, Didier Blaise, Péter Reményi, Federica Sorà, Jiri Pavlu, Stefania Bramanti, Alessandro Busca, Ana Berceanu, Giorgia Battipaglia, Giuseppe Visani, Gerard Sociè, Gesine Bug, Caterina Micò, Giorgio La Nasa, Maurizio Musso, Attilio Olivieri, Alexandros Spyridonidis, Bipin Savani, Fabio Ciceri, Arnon Nagler, Mohamad Mohty, on behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Publikováno v:
HemaSphere, Vol 7, Iss 10, p e952 (2023)
We conducted a registry analysis including adult acute myeloid leukemia (AML) patients in remission who had received thiotepa, busulfan, and fludarabine (TBF) or treosulfan-based (Treo) conditioning for haplo-hematopoietic stem cell transplant (HSCT)
Externí odkaz:
https://doaj.org/article/43bceaa88620409183d75baac3c88d12
Autor:
Francesco Autore, Stefania Bramanti, Federica Lessi, Idanna Innocenti, Eugenio Galli, Serena Rocchi, Rossella Ribolla, Daniele Derudas, Stefania Oliva, Paola Stefanoni, Magda Marcatti, Angelo Schenone, Giorgio La Nasa, Claudia Crippa, Elena Zamagni, Marcello Riva, Rita Mazza, Daniele Mannina, Simona Sica, Andrea Bacigalupo, Luca Laurenti
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Autologous peripheral blood stem cell transplantation (aPBSCT) provides optimal outcomes in POEMS syndrome but the definition of the best treatment before aPBSCT remains to be defined because of the rarity of the disease and the heterogeneity of publ
Externí odkaz:
https://doaj.org/article/49923cb4e2704333b3669372233d26c3
Autor:
Maria Pina Simula, Daniela Dessì, Sara Veronica Usai, Brunella Mola, Michela Schirru, Luca Deiana, Giorgio La Nasa
Publikováno v:
HemaSphere, Vol 7, p e9675201 (2023)
Externí odkaz:
https://doaj.org/article/42ddc730a7934e589604021081541105
Autor:
Stefano Mocci, Roberto Littera, Stefania Tranquilli, Aldesia Provenzano, Alessia Mascia, Federica Cannas, Sara Lai, Erika Giuressi, Luchino Chessa, Goffredo Angioni, Marcello Campagna, Davide Firinu, Maria Del Zompo, Giorgio La Nasa, Andrea Perra, Sabrina Giglio
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Sardinia has one of the lowest incidences of hospitalization and related mortality in Europe and yet a very high frequency of the Neanderthal risk locus variant on chromosome 3 (rs35044562), considered to be a major risk factor for a severe SARS-CoV-
Externí odkaz:
https://doaj.org/article/bd45465770fa42918eb39b483da90837
Autor:
Mario Petrini, Gianluca Gaidano, Andrea Mengarelli, Ugo Consoli, Armando Santoro, Anna Maria Liberati, Marco Ladetto, Vincenzo Fraticelli, Attilio Guarini, Donato Mannina, Paola Ferrando, Paolo Corradini, Pellegrino Musto, Caterina Stelitano, Dario Marino, Andrea Camera, Marco Murineddu, Roberta Battistini, Giuseppe Caparrotti, Mauro Turrini, Luca Arcaini, Simone Santini, Manuela Cerqueti, Andres J. M. Ferreri, Nicola Cantore, Alessandro Inzoli, Giovanni Cardinale, Benedetto Ronci, Giorgio La Nasa, Stefano Massimi, Gianfranco Gaglione, Valentina Barbiero, Maurizio Martelli
Publikováno v:
Advances in Hematology, Vol 2022 (2022)
Subcutaneous (SC) rituximab may be beneficial in terms of convenience and tolerability, with potentially fewer and less severe administration-related reactions (ARRs) compared to the intravenous (IV) form. This report presents the results of a phase
Externí odkaz:
https://doaj.org/article/3480b587a0d945b293f445ff21680c7d
Autor:
Giovanni Caocci, Daniela Fanni, Mariagrazia Porru, Marianna Greco, Sonia Nemolato, Davide Firinu, Gavino Faa, Angelo Scuteri, Giorgio La Nasa
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Externí odkaz:
https://doaj.org/article/32bb199925e4466cbdca3ed3253e8d6e
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Off-target effects in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) are associated with cardiovascular toxicity. Hypertension represents an important cardiovascular complication and, if not appropr
Externí odkaz:
https://doaj.org/article/1d927045b1b44731acea9e2aa0d721a4
Publikováno v:
Diagnostics, Vol 12, Iss 10, p 2493 (2022)
Numerous prognostic indexes have been developed in hematological diseases based on patient characteristics and genetic or molecular assessment. However, less attention was paid to more accessible parameters, such as neutrophils, lymphocytes, monocyte
Externí odkaz:
https://doaj.org/article/e5ca17e086bf47e0be0c64994b5983fe